On 13 & 14 April 2011, the 5th session of the Civil Society Forum on Drug Policy in the EU was held in Brussels. Frederick Polak and Bruno Valkeneers participated on behalf of Encod.
In this letter written to the European Parliament in september 2005, Encod encouraged the EP to make a start with the organisation of a true dialogue between citizens and authorities on drug policy in the EU. 6 years later, we are still waiting.
Questions posed by Members of European Parliament Dennis DE JONG, GUE/NGL, SP and Sophie IN ‘T VELD, ALDE, D66 (Netherlands),
On 8 November, the meeting of the core group of the EU Civil Society Forum on Drug Policy took place. Encod is a member of this group (together with Correlation, Irefrea, INPUD, EHRN and EURAD). The first meeting of the core group took place on 15 June 2010.
In an answer to a parliamentary question, Eurocommissioner Viviane Reding announces a new evaluation of drug policy in the European Union. The question remains if its conclusions will have any impact on policymaking at all.
ENCOD was invited to the fourth session of the Civil Society Forum on EU Drug Policy that will be held on December 13th and 14th 2010 in Brussels, Belgium. The agenda of this meeting was prepared at the meeting of the core group to take place on 8 November 2010 Read also the report on […]
After the event you will be able to see a video registration here READ THE PRESS RELEASE READ THE CONFERENCE FOLDER
ENCOD’s Position Paper for the Civil Society Forum on Drug Policy in the European Union
On 15 June, the European Commission organised a meeting of the core group of the EU Civil Society Forum on Drug Policy. Encod is a member of this group (together with Correlation, Irefrea, INPUD, EHRN and EURAD). The core group was formed during the last session of the CSF in March 2009.
Date: 23 february 2010 from 10 – 16 hs Place: European Parliament, Brussels, Room A1E-3 The hearing was organised in collaboration with Member of European Parliament Michail Tremopoulos of Greece (GREENS/EFA). READ THE CONCLUSIONS AND THE PRESS RELEASE OF THE HEARING